You Searched For "bharat biotech covid vaccine trial" and got 20 results
Sort By:
2 mins read
BHU study on Covaxin side effects poorly designed, critically flawed: ICMR Director General
The Indian Council of Medical Research Director General Dr Rajiv Bahl has criticised a recently pub…
PTI
1 min read
Bharat Biotech's intranasal Covid vaccine approved by govt, to be available on CO-WIN
Prime Minister Narendra Modi had on Thursday cautioned people against complacency and urged…
PTI
2 mins read
Biological E, Bharat Biotech together sitting on stockpile of 250 million COVID vaccine doses
stockpile of 50 million doses of Covaxin. Dr Vikram Paradkar, Executive Vice President (M…
PTI
2 mins read
Bharat Biotech's nasal Covid vaccine to be priced at ₹800 for private and ₹325 for govt hospitals
Bharat Biotech's nasal COVID-19 vaccine iNCOVACC, which was given approval as a booster dose, will …
ANI
2 mins read
Covaxin shows 77.8% effectiveness against symptomatic COVID-19 cases in phase-3 trials
The efficacy analysis demonstrates Covaxin to be 93.4 per cent effective against severe symptoma…
PTI
2 mins read
Bharat Biotech’s Covaxin shows 81% efficacy after second dose in phase 3 trials
Hyderabad-based Bharat Biotech released phase 3 results of its Covid-19 vaccine — Covaxin — today. …
4 mins read
Bharat Biotech sees rivals’ conspiracy in all the criticism for the approval for Covaxin
Bharat Biotech chairman and managing director, Krishna Ella, believes that the gossip-mongering …
2 mins read
COVID-19 vaccine Covaxin: Bharat Biotech to begin Phase II trials soon
These trials of the BBV152 coronavirus vaccine or Covaxin will be conducted on 380 participants,…
2 mins read
Bharat Biotech's COVID-19 vaccine COVAXIN is well tolerated with no serious adverse events as per phase 1 trial results
A preprint is a version of a scientific manuscript posted on a public server prior to formal pe…
PTI
2 mins read
Bharat Biotech to start Phase-1 trials for its second COVID-19 vaccine in Feb-March
Besides Covaxin, Bharat Biotech has been actively working on developing another vaccine, for whi…
PTI
2 mins read
Ideal time for COVID-19 booster shot is six months after the second dose, says Bharat Biotech MD
"The ideal time for a booster dose is six months after the second dose," Ella stated. Abo…
PTI
8 mins read
COVID-19 vaccine updates in India: Oxford’s COVID-19 vaccine trials can be over by December, if SII doesn’t go for emergency licence
Scientists are still looking for a cure for the deadly coronavirus, which has infected millions of …
2 mins read
WHO approves Bharat Biotech’s Covaxin for emergency use after a long wait
The WHO, in a tweet, said: "WHO has granted emergency use listing (EUL) to Covaxin, developed by…
1 min read
Covaxin vaccine update: Bharat Biotech brings on board 13,000 volunteers for Phase III trials across multiple sites in India
The Phase III human clinical trials of Covaxin began mid-November, targeted to be done in 26,000…
2 mins read
India COVID-19 vaccine tracker — Oxford’s phase III trial and Bharat Biotech, Zydus Cadila’s phase II trial results likely in November
India is witnessing a downward trend in new COVID-19 infections daily — and has managed to record 6…
2 mins read
India's first vaccine candidate - Bharat Biotech's Covaxin begins its Phase-3 trials
Hyderabad, Nov (IANS) Vaccine maker Bharat Biotech on Monday announced that it has commenced Phase-…
1 min read
Bharat Biotech applies for emergency use approval for its COVID-19 vaccine Covaxin
Covaxin is being indigenously developed by Bharat Biotech in collaboration with the Indian Coun…
PTI
4 mins read
Supreme Court wants the Indian government to explain vaccine pricing — and clarify how many doses it will need as coverage expands from May 1
The Supreme Court of India has decided it cannot be a “mute spectator” as the number of new COVID-1…
1 min read
India's drug regulator asks Dr Reddy's for more data, as it reviews emergency use of Covid-19 vaccine Sputnik V
The Central Drug Standard Control Organisation's (CDSCO)Subject Expert Committee has asked Dr Reddy…
3 mins read
COVID-19 vaccine latest updates: Sinovac’s CoronaVac safe, early trial results show that vaccine triggers immune response
It takes a decade or two to design, test, and launch an effective vaccine that can protect billi…